Abstract
Background
Treatment-related infertility is an important issue for cancer survivors of reproductive age. We aimed to determine the understanding and management of fertility issues in cancer survivors by health care providers.
Methods
We studied 112 patients aged 15–40 years who underwent chemotherapy in Tokushima University Hospital. The gynecologists and oncologists who treated these patients were surveyed regarding their concerns about infertility issues in young cancer survivors.
Results
Of the 112 women studied, 57 had iatrogenic amenorrhea. Five were referred to reproductive specialists before or during treatment. Three patients with breast cancer were referred after treatment; they could not undergo fertility treatment due to ovarian failure after chemotherapy. Forty-five medical doctors answered the survey: 21 gynecologists (including 9 fertility specialists), 13 oncologists, and 11 surgeons. Of the oncologists and surgeons, 37.5 % (9/24) referred their patients to fertility experts. They listed certain issues regarding the patients: (1) anxiety that the intervention will alter the prognosis by delaying cancer treatment, and (2) a lack of communication between the oncologist and the fertility specialist. Almost all physicians agreed that fertility counseling was needed before chemotherapy.
Conclusion
This report showed the importance of oncofertility counseling and cooperation between oncologists and fertility specialists. Fertility in cancer survivors depends on type of cancer treatment applied, chemotherapy regimen, and age at treatment. Our institute is now equipped for oncofertility counseling and refers patients for fertility preservation prior to cancer treatment.
Similar content being viewed by others
References
Nieman CL, Kazer R, Brannigan RE et al (2006) Cancer survivors and infertility: a review of a new problem and novel answers. J Support Oncol 4:171–178
Konishi I, Irahara M (2014) In the opinion regarding the medical suitability of harvesting, freezing, and preservation of unfertilized eggs and ovary tissue according to medical indication (in Japanese). http://www.jsog.or.jp/ethic/mijyuseiranshi_20140417.html. Accessed 07 July 2016
Saito H (2013) The annual assisted reproductive technology report 2010 (in Japanese). Jpn Soc Obstet Gynecol 64:2110–2140
Lee SJ, Schover LR, Partridge AH et al (2006) American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 24:2917–2931
Meirow D, Dor J, Kaufman B et al (2007) Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury. Hum Reprod 22:1626–1633
Bastings L, Baysal O, Beerendonk CC et al (2014) Referral for fertility preservation counseling in female cancer patients. Hum Reprod 29:2228–2237
Loren AW, Mangu PB, Beck LN et al (2013) Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31:2500–2511
Woodruff TK (2015) Oncofertility: a grand collaboration between reproductive medicine and oncology. Reproduction 150:S1–S10
von Wolff M, Montag M, Dittrich R et al (2011) Fertility preservation in women—a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin’s lymphoma and borderline ovarian tumors by the fertility preservation network FertiPROTEKT. Arch Gynecol Obstet 284:427–435
Ronn R, Holzer HE (2013) Oncofertility in Canada: an overview of Canadian practice and suggested action plan. Curr Oncol 20:e465–e474
von Wolff M, Dian D (2012) Fertility preservation in women with malignant tumors and gonadotoxic treatments. Dtsch Arztebl Int 109:220–226
Kagawa N (2014) Forefront ovary and egg bank for cancer patients (in Japanese). In: Proc 55th Annu Meeting of Japan Society for Ova Research, Kobe, Japan, 17–18 May 2014
Bittinger SE, Nazaretian SP, Gook DA et al (2011) Detection of Hodgkin lymphoma within ovarian tissue. Fertil Steril 95(803e):3–6
Gerber B, von Minckwitz G, Stehle H et al (2011) Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 27 ZORO study. J Clin Oncol 29:2334–2341
Menken J, Trussell J, Larsen U (1986) Age and infertility. Science 26:1389–1394
Martin JA, Hamilton BE, Osterman MJ et al (2015) Births: final data for 2013. Natl Vital Stat Rep 64:1–65
Pavone ME, Hirshfeld-Cytron J, Lawson AK et al (2014) Fertility preservation outcomes may differ by cancer diagnosis. J Hum Reprod Sci 7:111–118
Ruddy KJ, Gelber SI, Tamimi RM et al (2014) Prospective study of fertility concerns and preservation strategies in young women with breast cancer. J Clin Oncol 32:1151–1156
Mersereau JE, Goodman LR, Deal AM et al (2013) To preserve or not to preserve: how difficult is the decision about fertility preservation? Cancer 119:4044–4050
Acknowledgments
We wish to thank the doctors for cooperating with our enquiries and helping with the questionnaire. No funding was received for this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Appendix: Doctor’s questionnaire
Appendix: Doctor’s questionnaire
About this article
Cite this article
Abe, A., Kuwahara, A., Iwasa, T. et al. A survey on fertility management in young women of reproductive age treated with chemotherapy. Int J Clin Oncol 21, 1183–1190 (2016). https://doi.org/10.1007/s10147-016-1018-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-016-1018-5